Clinical trial
A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And…
NCT00134498 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00134498 |
|---|---|
| Title | A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides |
| Official title | Phase 3, Multi-Site, Double-Blind, Randomized, Forced Titration, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (CP 529,414)/Atorvastatin Administered Orally, Once Daily (Qd) For Eighteen Weeks, Compared With Atorvastatin Alone, In Subjects With… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia, Hyperlipoproteinemia Type IV |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 160 |
| Start date | Feb 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Nov 16, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: